| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |